Regeneron

Watch out, Merck: FDA grants Regeneron, Sanofi's Libtayo priority review for coveted first-line use in lung cancer
Fierce Pharma
Thu, 10/29/20 - 12:17 pm
Regeneron
Sanofi
Libtayo
FDA
priority review
non-small cell lung cancer
Merck
Keytruda
Regeneron posts second look on Covid-19 antibody cocktail, boosting its case for EUA — but what about symptom alleviation?
Endpoints
Thu, 10/29/20 - 12:04 pm
Regeneron
COVID-19
antibodies
FDA
Emergency Use Authorization
Regeneron scientists pinpoint genes related to COVID-19 susceptibility and severity
Fierce Biotech
Wed, 10/28/20 - 11:12 pm
Regeneron
gene sequencing
COVID-19
genomics
Sanofi, Regeneron chase 4th Dupixent approval with rare esophageal disease data
Fierce Pharma
Mon, 10/26/20 - 11:04 pm
Sanofi
Regeneron
FDA
Dupixent
eosinophilic esophagitis
FDA approves Regeneron antibody drug as first Ebola virus treatment
BioPharma Dive
Wed, 10/14/20 - 09:04 pm
Regeneron
FDA
antibodies
ebola virus
Dupixent Posts Positive Results in Phase III Pediatric Asthma Study
BioSpace
Tue, 10/13/20 - 11:06 am
Regeneron
Sanofi
pediatric
asthma
clinical trials
Dupixent
Amid Regeneron's emergency use bid, former FDA chief says US 'too late' on mass manufacture of COVID-19 antibodies
Fierce Pharma
Mon, 10/12/20 - 10:34 am
Donald Trump
Scott Gottlieb
FDA
Regeneron
antibodies
COVID-19
Regeneron CEO cautions Trump’s results are ‘a case of one,’ and coronavirus drug needs more testing
Marketwatch
Sun, 10/11/20 - 10:21 pm
Regeneron
Donald Trump
antibodies
COVID-19
clinical trials
Regeneron submits request for EUA for COVID-19 antibody cocktail
Biopharma Reporter
Thu, 10/8/20 - 11:12 am
Regeneron
antibodies
COVID-19
Donald Trump
Emergency Use Authorization
Trump Touts Regeneron in Video Message
TheStreet.com
Wed, 10/7/20 - 11:28 pm
Regeneron
Donald Trump
politics
antibodies
COVID-19
Regeneron execs go on a whirlwind media tour after Trump takes COVID-19 antibody cocktail
Fierce Pharma
Wed, 10/7/20 - 10:56 am
Regeneron
COVID-19
Donald Trump
antibody cocktail
Regeneron CEO Says Trump Receiving Experimental Antibody Treatment Creates ‘Very Tough Situation’
Forbes
Mon, 10/5/20 - 11:47 pm
Regeneron
Donald Trump
COVID-19
Pharma CEOs
Leonard Schleifer
Regeneron Shares Jump On FDA Hopes After Trump Receives Its Experimental COVID-19 Treatment
TheStreet.com
Mon, 10/5/20 - 10:54 am
Regeneron
Emergency Use Authorization
FDA
COVID-19
Donald Trump
Go or no go? Vaccine panel upstages US approval decisions
EP Vantage
Fri, 10/2/20 - 12:44 pm
FDA
vaccines
COVID-19
advisory panel
Eysuvis
Brilinta
Kala Pharmaceuticals
dry eye disease
Regeneron
AstraZeneca
stroke
5 FDA approval decisions to watch in the 4th quarter
BioPharma Dive
Wed, 09/30/20 - 10:45 am
FDA
drug approvals
vaccines
Pfizer
Moderna Therapeutics
COVID-19
Regeneron
EB3
ebola virus
Alkermes
ALKS-3831
schizophrenia
bipolar disorder
Bristol-Myers Squibb
liso-cel
non-Hodgkin lymphoma
roxadustat
FibroGen
chronic kidney disease
Regeneron says antibody drug may speed recovery of patients with mild COVID-19
BioPharma Dive
Tue, 09/29/20 - 11:32 pm
Regeneron
antibodies
COVID-19
ESMO: Regeneron and Sanofi gun for Libtayo in first-line NSCLC with fresh survival stats
Fierce Pharma
Mon, 09/21/20 - 10:57 am
Libtayo
ESMO
Regeneron
Sanofi
non-small cell lung cancer
Sanofi/Regeneron’s Libtayo set for new skin cancer use
Pharmaforum
Fri, 09/18/20 - 10:40 am
Sanofi
Regeneron
Libtayo
clinical trials
skin cancer
Sanofi, Regeneron get FDA breakthrough therapy status for Dupixent to treat eosinophilic esophagitis
Pharmaceutical Business Review
Mon, 09/14/20 - 10:50 am
Sanofi
Regeneron
Dupixent
FDA
eosinophilic esophagitis
breakthrough status
Novartis says Beovu matched rival Eylea in visual acuity in eye disease
Pharma Live
Mon, 09/14/20 - 10:41 am
Novartis
Beovu
Eylea
Regeneron
diabetic macular edema
clinical trials

Pages